Evidence map›Paper›PMID 35147468›Full record

ArticleJournal of women's health (2002)2022

A Field Placement Approach to Enhance State and Local Capacity for Opioid-Related Issues Affecting Pregnant and Postpartum People and Infants Prenatally Exposed to Opioids and Other Substances.

Mary Kate Weber, Emmy L Tran, Charlan D Kroelinger, Celeste Ellison, Trisha Mueller, Lisa Romero, Kecia L Ellick, Marion E Rice, Gabriela Garcia, Ellen Pliska and 5 more

Abstract read
In one paragraph

Article in Journal of women's health (2002), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mary Kate WeberDivision of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, Georgia, USA.
Emmy L TranDivision of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, Georgia, USA.
Charlan D KroelingerDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia, USA.
Celeste EllisonRollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Trisha MuellerDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia, USA.
Lisa RomeroDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia, USA.
Kecia L EllickCDC Foundation, Atlanta, Georgia, USA.
Marion E RiceDivision of Parasitic Diseases and Malaria, Center for Global Health, CDC, Atlanta, Georgia, USA.
Gabriela GarciaAssociation of State and Territorial Health Officials, Arlington, Virginia, USA.
Ellen PliskaAssociation of State and Territorial Health Officials, Arlington, Virginia, USA.
Sanaa AkbaraliAssociation of State and Territorial Health Officials, Arlington, Virginia, USA.
Ramya DronamrajuAssociation of State and Territorial Health Officials, Arlington, Virginia, USA.
Katrin PattersonAssociation of State and Territorial Health Officials, Arlington, Virginia, USA.
S Nicole FehrenbachDivision of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, Georgia, USA.
Wanda D BarfieldDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia, USA.

Funding

CDC HHSIntramural CDC HHS CC999999
6 · The paper itself

Abstract

Opioid use disorder (OUD) poses a significant public health concern impacting maternal and infant outcomes. In 2018, the Centers for Disease Control and Prevention (CDC) partnered with the Association of State and Territorial Health Officials (ASTHO) to develop the Opioid use disorder, Maternal outcomes, and Neonatal abstinence syndrome Initiative Learning Community (OMNI LC) to identify and disseminate best practices and strategies for implementing systems-level changes in state health departments to address OUD affecting pregnant and postpartum persons and infants prenatally exposed to opioids. In 2019, the OMNI LC incorporated a field placement approach that assigned temporary field placement staff in five select OMNI LC states to provide important linkages, facilitate information sharing, and strengthen capacity among state and local health departments and other partners supporting maternal and child health communities affected by the opioid crisis. Using an implementation science framework, the field placement approach was assessed using five implementation outcome measures: appropriateness, acceptability, implementation cost, sustainability, and feasibility. Written responses from the participating OMNI LC states on these implementation outcome measures were analyzed to (1) highlight key strategies used by field placement staff, (2) assess the implementation of the OMNI LC field placement approach within the context of implementation science, and (3) identify implementation barriers. This report describes the implementation of a temporary field placement approach and suggests that this approach could be replicated to enhance state and local capacity to respond to the opioid crisis or other high-consequence events.

Indexed as

Neonatal Abstinence SyndromeOpioid-Related DisordersAnalgesics, OpioidCenters for Disease Control and Prevention, U.S.ChildFemaleHumansInfantInfant, NewbornPostpartum PeriodPregnancyUnited StatesAnalgesics, Opioidcapacity buildinglearning collaborativesneonatal abstinence syndromeopioid use disorderpregnancy

Identifiers

PMID35147468
PMCPMC9185753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.